Redi Health

About Redi Health

Redi Health connects pharmaceutical manufacturers to patients through a highly-targeted approach to drive new patient acquisition and medication adherence. Their mission is to enhance patient outcomes and maximize investment for life science companies while empowering patients with tools for health management.

Products & Services

CONNECT:A service to link pharmaceutical manufacturers with patients, focusing on patient acquisition and therapy journey support.

NAVIGATOR:A tool designed to assist patients and providers in navigating healthcare and improving adherence and outcomes.

Patient Tools:Free comprehensive tools for patients to manage their health and well-being effectively.

Specialties

Patient Acquisition Medication Adherence Health Management Tools Life Sciences Support

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 14000000 MR: - FA: $14 million FAN: 14000000	D: 2024-02-28 FD: 2024-02-28	6 investors

Series B Latest

2024-02-28

$14.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Luke Buchanan

Chief Executive Officer

J

Jaimin Gandhi

Chief Technology Officer

N

Nate Rehm

Head of Business Development

K

Kyle Grimslid

Chief Strategy Officer

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Redi Health Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised